- Home
- FWRG vs BLFS Comparison
FWRG vs BLFS Comparison
Compare FWRG & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FWRG
- BLFS
- Stock Information
- Founded
- FWRG 1983
- BLFS 1987
- Country
- FWRG United States
- BLFS United States
- Employees
- FWRG N/A
- BLFS N/A
- Industry
- FWRG Restaurants
- BLFS Medical/Dental Instruments
- Sector
- FWRG Consumer Discretionary
- BLFS Health Care
- Exchange
- FWRG Nasdaq
- BLFS Nasdaq
- Market Cap
- FWRG 970.4M
- BLFS 995.2M
- IPO Year
- FWRG 2021
- BLFS 1989
- Fundamental
- Price
- FWRG $17.66
- BLFS $22.68
- Analyst Decision
- FWRG Strong Buy
- BLFS Strong Buy
- Analyst Count
- FWRG 10
- BLFS 7
- Target Price
- FWRG $22.20
- BLFS $30.86
- AVG Volume (30 Days)
- FWRG 1.1M
- BLFS 424.1K
- Earning Date
- FWRG 08-05-2025
- BLFS 08-07-2025
- Dividend Yield
- FWRG N/A
- BLFS N/A
- EPS Growth
- FWRG N/A
- BLFS N/A
- EPS
- FWRG 0.06
- BLFS N/A
- Revenue
- FWRG $1,105,027,000.00
- BLFS $93,468,000.00
- Revenue This Year
- FWRG $21.66
- BLFS $21.22
- Revenue Next Year
- FWRG $16.02
- BLFS $17.50
- P/E Ratio
- FWRG $297.74
- BLFS N/A
- Revenue Growth
- FWRG 14.53
- BLFS 45.60
- 52 Week Low
- FWRG $12.90
- BLFS $19.10
- 52 Week High
- FWRG $22.71
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- FWRG 53.06
- BLFS 57.68
- Support Level
- FWRG $16.04
- BLFS $20.23
- Resistance Level
- FWRG $19.50
- BLFS $21.31
- Average True Range (ATR)
- FWRG 1.01
- BLFS 1.00
- MACD
- FWRG 0.03
- BLFS 0.03
- Stochastic Oscillator
- FWRG 46.82
- BLFS 65.97
About FWRG First Watch Restaurant Group Inc.
First Watch Restaurant Group Inc is a daytime restaurant concept serving made-to-order breakfast, brunch, and lunch using fresh ingredients. It generates revenues from Restaurant sales and Franchise revenues.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.